BAX 826 Dose-Escalation Safety Study

NCT02716194 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

BIOLOGICAL: BAX 826
BIOLOGICAL: Octocog alfa

Sponsor

Baxalta now part of Shire